The combination of 4-1BBL and CD40L strongly enhances the capacity of dendritic cells to stimulate HIV-specific T cell responses-Reference-Cited by-同舟云学术

The combination of 4-1BBL and CD40L strongly enhances the capacity of dendritic cells to stimulate HIV-specific T cell responses

Published:2011-03-22 Issue:6 Volume:89 Page:989-999
ISSN:0741-5400
Container-title:Journal of Leukocyte Biology
language:en
Short-container-title:Journal of Leukocyte Biology

Author:

De Keersmaecker Brenda,Heirman Carlo,Corthals Jurgen,Empsen Christophe,van Grunsven Leo A.,Allard Sabine D.,Pen Joeri,Lacor Patrick,Thielemans Kris,Aerts Joeri L.

Funder

DC-THERA network

Cancer Immunology and Immunotherapy Research Project

Institute for Science and Technology

University Research Fund

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Reference69 articles.

1. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells;Betts;Blood,2006

2. Safety of autologous, ex vivo-expanded human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte infusion in HIV-infected patients;Lieberman;Blood,1997

3. Therapeutic dendriticcell vaccine for chronic HIV-1 infection;Lu;Nat. Med.,2004

4. De Keersmaecker , B. Thielemans , K. Aerts , J. L. 2011 Curr. Mol. Med.

5. CD137 expression in tumor vessel walls. High correlation with malignant tumors;Broll;Am. J. Clin. Pathol.,2001

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Path towards mRNA delivery for cancer immunotherapy from bench to bedside;Theranostics;2024

2. GITR activation ex vivo impairs CD8 T cell function in people with HIV on antiretroviral therapy;iScience;2023-11

3. Advancing Cancer Immunotherapy: The Potential of mRNA Vaccines As a Promising Therapeutic Approach;Advanced Therapeutics;2023-10-15

4. Dendritic Cell Vaccines: A Shift from Conventional Approach to New Generations;Cells;2023-08-25

5. The Quest for mRNA Vaccines;Nucleic Acid Therapeutics;2022-12-01